AVTR
Undervalued by 3.9% based on the discounted cash flow analysis.
Market cap | $17.59 Billion |
---|---|
Enterprise Value | $22.86 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.47 |
Beta | 0.8 |
Outstanding Shares | 678,281,383 |
Avg 30 Day Volume | 4,038,888 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 54.77 |
---|---|
PEG | -179.66 |
Price to Sales | 2.56 |
Price to Book Ratio | 3.65 |
Enterprise Value to Revenue | 3.28 |
Enterprise Value to EBIT | 26.67 |
Enterprise Value to Net Income | 71 |
Total Debt to Enterprise | 0.24 |
Debt to Equity | 1.05 |
No data
No data
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.